Stock REMEDY REMEDY ENTERTAINMENT OYJ
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Remedy Entertainment Oyj

Equities

REMEDY

FI4000251897

Market Closed - Nasdaq Helsinki
Other stock markets
 11:29:51 2024-05-27 am EDT 		5-day change 1st Jan Change
19.34 EUR +0.73% Intraday chart for Remedy Entertainment Oyj -3.30% -23.86%
May. 08 Terhi Kauppi Resigns as Chief Financial Officer of Remedy Entertainment Plc, Effective June 30, 2024 CI
Apr. 29 Transcript : Remedy Entertainment Oyj, Q1 2024 Earnings Call, Apr 29, 2024

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • Analyst opinion has improved significantly over the past four months.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • With an enterprise value anticipated at 5.16 times the sales for the current fiscal year, the company turns out to be overvalued.
  • The company appears highly valued given the size of its balance sheet.
  • The company is not the most generous with respect to shareholders' compensation.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Software

1st Jan change Capi. Investor Rating ESG Refinitiv
REMEDY ENTERTAINMENT OYJ Stock Remedy Entertainment Oyj
-24.72% 282M -
MICROSOFT CORPORATION Stock Microsoft Corporation
+14.39% 3,197B
C+
SYNOPSYS INC. Stock Synopsys Inc.
+14.08% 89.6B
B
CADENCE DESIGN SYSTEMS, INC. Stock Cadence Design Systems, Inc.
+8.04% 80.08B
B+
DASSAULT SYSTÈMES SE Stock Dassault Systèmes SE
-12.33% 55.52B
B+
PALANTIR TECHNOLOGIES INC. Stock Palantir Technologies Inc.
+22.36% 46.79B
D+
THE TRADE DESK, INC. Stock The Trade Desk, Inc.
+31.67% 46.34B
D+
ATLASSIAN CORPORATION Stock Atlassian Corporation
-29.01% 43.95B
B-
SEA LIMITED Stock Sea Limited
+77.73% 41.34B
D+
TAKE-TWO INTERACTIVE SOFTWARE, INC. Stock Take-Two Interactive Software, Inc.
-3.95% 26.5B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. REMEDY Stock
  4. Ratings Remedy Entertainment Oyj